A single arm, multicenter, phase II trial of oxaliplatin plus capecitabine in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)

被引：0
|
作者：
Tianshu, L. [1 ]
Yu, Y. [1 ]
Sun, Y. [2 ]
Min, Y. [3 ]
Cao, H. [4 ]
Yingbin, L. [5 ]
Wang, Y. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Med Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Gen Surg, Coll Med, Shanghai, Peoples R China
[4] Shanghai Renji Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A single arm, open-label, multicenter, phase II trial of oxaliplatin plus capecitabine (XELOX) in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)
    Liu, T.
    Yu, Y.
    Sun, Y.
    Yan, M.
    Cao, H.
    Liu, Y.
    Wang, X.
    Shen, Z.
    Liu, F.
    Wang, Y.
    Feng, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 68 - 68
  • [2] Oxaliplatin plus capecitabine (XELOX) in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC).
    Liu, Tianshu
    Yu, Yiyi
    Fang, Yong
    Shen, Zhenbin
    Yan, Min
    Cao, Hui
    Liu, Yingbin
    Wang, Xuefei
    Cui, Yuehong
    Wang, Yan
    Liu, Fenlin
    Chen, Weidong
    Li, Wei
    Sun, Yihong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study
    Yu, Yiyi
    Fang, Yong
    Shen, Zhenbin
    Wang, Yan
    Yan, Min
    Cao, Hui
    Liu, Yingbin
    Wang, Xuefei
    Cui, Yuehong
    Liu, Fenglin
    Chen, Weidong
    Li, Wei
    Li, Qian
    Jiang, Huiqin
    Sun, Yihong
    Liu, Tianshu
    ONCOLOGIST, 2019, 24 (10): : 1311 - +
  • [4] Oxaliplatin and capecitabine (XELOX) plus toripalimab as perioperative treatment for locally advanced gastric or gastro-esophageal junction adenocarcinoma (Neo-Capture): A single-arm, phase 2 study.
    Jiang, Zhichao
    Xie, Yibin
    Wang, Bingzhi
    Zhu, Yongjian
    Ke, Yan
    Zhang, Wen
    Sun, Yongkun
    Li, Yin
    Wang, Chengfeng
    Zhao, Dongbing
    Tian, Yantao
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16002 - E16002
  • [5] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Hasegawa, J.
    Kato, T.
    Nishimura, J.
    Yoshioka, S.
    Noura, S.
    Kagawa, Y.
    Yasui, M.
    Ikenaga, M.
    Murata, K.
    Hata, T.
    Matsuda, C.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
    Ji, J.
    Shen, L.
    Li, Z.
    Zhang, X.
    Liang, H.
    Xue, Y.
    Wang, Y.
    Zhou, Z.
    Yu, J.
    Chen, L.
    Du, Y.
    Li, G.
    Xiao, G.
    Wu, D.
    Zhou, Y.
    Dang, C.
    He, Y.
    Zhang, Z.
    Sun, Y.
    Li, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 877 - 877
  • [7] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Junichi Nishimura
    Junichi Hasegawa
    Takeshi Kato
    Shinichi Yoshioka
    Shingo Noura
    Yoshinori Kagawa
    Masayoshi Yasui
    Masakazu Ikenaga
    Kohei Murata
    Taishi Hata
    Chu Matsuda
    Tsunekazu Mizushima
    Hirofumi Yamamoto
    Yuichiro Doki
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 707 - 716
  • [8] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Nishimura, Junichi
    Hasegawa, Junichi
    Kato, Takeshi
    Yoshioka, Shinichi
    Noura, Shingo
    Kagawa, Yoshinori
    Yasui, Masayoshi
    Ikenaga, Masakazu
    Murata, Kohei
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 707 - 716
  • [9] Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin with Concurrent Radiation Therapy in the Treatment of Gastric Cancer after D2 Gastrectomy
    Xie, C.
    Chen, D.
    Jin, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S28 - S29
  • [10] Capecitabine plus oxaliplatin versus capecitabine plus oxaliplatin with concurrent radiotherapy in the treatment of gastric cancer after D2 gastrectomy.
    Xie, Congying
    Jin, Xiance
    Chen, Didi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345